Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?
Nonmedical biosimilar switching policies did not lead to increases in other health care service use and costs.
Authors
- Michael R. Law (ORCID: https://orcid.org/0000-0002-5637-6053)
- Mark Harrison (ORCID: https://orcid.org/0000-0002-2115-2447)
- Nick Bansback
- Sandra Blitz
- Hien Thanh Thi Dang
Institutions
- University of British Columbia (CA)
- Centre for Advancing Health Outcomes (CA)
- Arthritis Research Centre of Canada (CA)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1002/acr.25610
- Citations
- 1
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.80